The impact of dermatological toxicities of anti-cancer therapy on the dermatological quality of life of cancer patients

Journal of the European Academy of Dermatology and Venereology

Volumn 27, Issue 1, 2013, Pages

  Ra, H S ^a   Shin, S J ^b   Kim, J H ^b   Lim, H ^b   Cho, B C ^a   Roh, M R ^b  

^a Sunlin University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CANCER THERAPY; DRINKING BEHAVIOR; DRY SKIN; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; FLUSHING; HAIR LOSS; HAND FOOT SYNDROME; HUMAN; HYPERPIGMENTATION; KIDNEY CARCINOMA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAIL DISEASE; OBSERVATIONAL STUDY; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITUS; QUALITY OF LIFE; SKIN CARE; SKIN PROTECTION; SKIN TOXICITY; SMOKING; STOMACH CANCER; TREATMENT DURATION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CONFIDENCE INTERVALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG ERUPTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; KOREA; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEOPLASMS; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; SKIN DISEASES; TIME FACTORS; YOUNG ADULT;

EID: 84872844201     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2012.04466.x     Document Type: Article

References (29)

1. Haley AC, Calahan C, Gandhi M, et al. Skin care management in cancer patients: an evaluation of quality of life and tolerability. Support Care Cancer 2011; 19: 545-554.
2. Zabora J, BrintzenhofeSzoc K, Curbow B, et al. The prevalence of psychological distress by cancer site. Psychooncology 2001; 10: 19-28.
3. Wagner LI, Lacouture ME,. Dermatologic toxicities associated with EGFR inhibitors: the clinical psychologist's perspective. Impact on health-related quality of life and implications for clinical management of psychological sequelae. Oncology (Williston Park) 2007; 21: 34-36.
4. Finlay AY, Khan GK,. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216.
5. Jin-gang A, Sheng-xiang X, Sheng-bin X, et al. Quality of life of patients with scabies. J Eur Acad Dermatol Venereol 2010; 24: 1187-1191.
6. Lynch TJ, Jr, Kim ES, Eaby B, et al. Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management. Oncologist 2007; 12: 610-621.
7. Hongbo Y, Thomas CL, Harrison MA, et al. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Invest Dermatol 2005; 125: 659-664.
8. Lin TY, See LC, Shen YM, et al. Quality of life in patients with psoriasis in northern Taiwan. Chang Gung Med J 2011; 34: 186-196.
9. Byrd JW,. Arthroscopic hip surgery for the treatment of femoroacetabular impingement. Orthopedics 2011; 34: 186.
10. Tsai J, Salyers MP, McGuire AB,. A cross-sectional study of recovery training and staff attitudes in four community mental health centers. Psychiatr Rehabil J 2011; 34: 186-193.
11. Sauer WH, Lowery CM, Bargas RL, et al. Utility of postoperative testing of implantable cardioverter-defibrillators. Pacing Clin Electrophysiol 2011; 34: 186-192.
12. Silverman PM, Wechsler RJ, Griego D, et al. Cluster scanning in body CT. Abdom Imaging 1994; 19: 210-212.
13. Psaltis D, Mok F, Li HY,. Nonvolatile storage in photorefractive crystals. Opt Lett 1994; 19: 210.
14. Petereit HF, Moeller-Hartmann W, Reske D, et al. Rituximab in a patient with multiple sclerosis-effect on B cells, plasma cells and intrathecal IgG synthesis. Acta Neurol Scand 2008; 117: 399-403.
15. Lacouture ME, Mitchell EP, Piperdi B, et al. Skin toxicity evaluation protocol with panitumumab (STEPP), a phase II, open-label, randomized trial evaluating the impact of a pre-Emptive Skin treatment regimen on skin toxicities and quality of life in patients with metastatic colorectal cancer. J Clin Oncol 2010; 28: 1351-1357.
16. Heidecker J, Sahn SA,. Four faces of a parapneumonic effusion: pathophysiology and varied radiographic presentations. Respirology 2007; 12: 610-613.
17. Hymes SR, Strom EA, Fife C,. Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol 2006; 54: 28-46.
18. Hackbarth M, Haas N, Fotopoulou C, et al. Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women's cancers. Results of a prospective study. Support Care Cancer 2008; 16: 267-273.
19. DeSpain JD,. Dermatologic toxicity of chemotherapy. Semin Oncol 1992; 19: 501-507.
20. Boehncke WH, Ochsendorf F, Paeslack I, et al. Decorative cosmetics improve the quality of life in patients with disfiguring skin diseases. Eur J Dermatol 2002; 12: 577-580.
21. Renzi C, Abeni D, Picardi A, et al. Factors associated with patient satisfaction with care among dermatological outpatients. Br J Dermatol 2001; 145: 617-623.
22. Osio A, Mateus C, Soria JC, et al. Cutaneous side-effects in patients on long-term treatment with epidermal growth factor receptor inhibitors. Br J Dermatol 2009; 161: 515-521.
23. Wells M, Macmillan M, Raab G, et al. Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial. Radiother Oncol 2004; 73: 153-162.
24. Rhee JS, Matthews BA, Neuburg M, et al. The skin cancer index: clinical responsiveness and predictors of quality of life. Laryngoscope 2007; 117: 399-405.
25. Andreis F, Rizzi A, Mosconi P, et al. Quality of life in colon cancer patients with skin side effects: preliminary results from a monocentric cross sectional study. Health Qual Life Outcomes 2010; 8: 40.
26. Kent G, al-Abadie M,. Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers. Clin Exp Dermatol 1996; 21: 330-333.
27. Dolatshahi M, Ghazi P, Feizy V, et al. Life quality assessment among patients with vitiligo: comparison of married and single patients in Iran. Indian J Dermatol Venereol Leprol 2008; 74: 700.
28. Parsad D, Pandhi R, Dogra S, et al. Dermatology Life Quality Index score in vitiligo and its impact on the treatment outcome. Br J Dermatol 2003; 148: 373-374.
29. Rhee JS, Matthews BA, Neuburg M, et al. Quality of life and sun-protective behavior in patients with skin cancer. Arch Otolaryngol Head Neck Surg 2004; 130: 141-146.